Initial Data From The Phase 3 Keynote-811 Study Of Trastuzumab And Chemotherapy With Or Without Pembrolizumab For Her2-Positive Metastatic Gastric Or Gastroesophageal Junction (G/Gej) Cancer

Y. Janjigian,A. Kawazoe,P. Weber,S. Luo, S. Lonardi, O. Kolesnik, O. Barajas, Y. Bai,L. Shen,Y. Tang,L. Wyrwicz,K. Shitara, S. Qin,E. Van Cutsem, J. Tabernero, L. Li,C. Shih,P. Bhagia,H. Chung

ANNALS OF ONCOLOGY(2021)

引用 6|浏览2
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要